EpiGuard is proud to present the EpiShuttle – a single-patient isolation and transport system. During 2020, the EpiShuttle has become a gold standard within the transportation of patients with highly infectious diseases, such as Covid-19 and Ebola, on both sides of the Atlantic and is being used worldwide.
The unit is designed to provide maximum patient safety and comfort while allowing critical care and treatment to be performed by healthcare professionals. It can protect the environment from an infected patient or protect a vulnerable patient from a contaminated environment.
EpiGuard is an innovative medical technology company established in 2015 by a group of doctors at the Oslo University Hospital together with co-founders Inven2, Eker Group AS, and Hansen Protection AS. EpiGuard holds top-level expertise within product development and manufacturing. The medical background ranges from intensive care, infectious diseases, internal medicine, anesthesiology through transport medicine.